Medicare Rx medication therapy management
Centers for Medicare & Medicaid Services sets 2006 "cost threshold" for Medicare beneficiaries targeted for medication therapy management services under Part D benefit. Patient drug spending must be "likely to exceed" $4,000 a year for multiple chronic diseases. Overall, CMS is giving Medicare drug plans free rein in implementing required medication therapy management programs (1"The Pink Sheet" Feb. 7, 2005, p. 21)...
You may also be interested in...
The Centers for Medicare & Medicaid Services will give Part D plans free rein in implementing required medication therapy management programs
Despite AI and digital analytics playing an increasing role in pharma, the industry lags others globally, a recent event heard. Meanwhile, top Indian players including Sun Pharma, Cipla and others shared what is driving their initiatives, ranging from a 'touchless factory' to virtual training and lessons learned along the way.
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.